Read the post

Signia Therapeutics to be present at the Options for the Control of Influenza X Conference

August 20, 2019

Very pleased to announce that Dr. Andrés Pizzorno – Signia Therapeutics’ cofounder and Project Manager – has been invited by the Scientific Committee of the Options for the Control of Influenza X Conference, to be held in Singapore from August 28 to September 1 2019, to give a presentation on “Potential host-targeted therapies for influenza”.

The presentation – on Friday August 30 at 10.30 am – will showcase an update of the current clinical trial landscape in the field and a discussion on the future research directions in order to consolidate the host-targeted anti-influenza agents as an important contribution to our limited therapeutic arsenal, not only as putative standalone therapies but also with special focus on their combinatory potential with current classic virus-targeted inhibitors.

The Options X Conference is the premier global meeting focused on influenza, targeting more than 1,500 participants from across the globe. Visit the ISIRV Options X website (https://2019.isirv.org/) for detailed information.

 

Share it

Leave a comment

Contact us

Do not hesitate to contact us!

Location
L’Atrium – 43 boulevard du 11 novembre 1918 69100 Villeurbanne, France
Phone
(+33) 478771037
Email
contact@signiatherapeutics.com
Leave a comment

Signia therapeutics.com - Copyright 2018. All right reserved.